BIOMEDITECH ApS: Financial statements 2024
CVR: 34707847
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
BIOMEDITECH ApS (CVR 34707847) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 219,302 and a net result of DKK 290,046 compared with DKK 186,499 the year before. That is an increase of 58.8% compared with the year before. The profit margin was 132.3%. Equity in the 2024 report amounted to DKK 709,183. The solvency ratio was 80.4%.
- Revenue
- DKK 219,302
- Gross Profit
- DKK 219,302
- Profit/Loss
- DKK 290,046
- Equity
- DKK 709,183
- Total Assets
- DKK 882,527
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 219K | 219K | 290K | 709K | - |
| 2023 | 138K | 138K | 186K | 419K | - |
| 2022 | 112K | 112K | 106K | 233K | - |
| 2021 | - | - | 76K | 127K | - |
| 2020 | 27K | 27K | 17K | 51K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
BIOMEDITECH ApS has published its annual report for 2023. Revenue came to DKK 138,093, and the net result was DKK 186,499.
About BIOMEDITECH ApS
BIOMEDITECH ApS is a Danish company of the type Anpartsselskab based in Herlev, founded in 2012. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named DRUG TESTING EUROPE ApS. The management consists of Tobias Chalmer Stahl Rasmussen. The company is owned by Chalmer Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 106,895 and a net result of DKK -6,298 compared with DKK 290,046 the year before. Equity in the 2025 report amounted to DKK 877,884.